Cleared Special

K000363 - MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM (FDA 510(k) Clearance)

Feb 2000
Decision
14d
Days
Class 2
Risk

K000363 is an FDA 510(k) clearance for the MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM. This device is classified as a Thyroglobulin, Antigen, Antiserum, Control (Class II - Special Controls, product code DDC).

Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on February 18, 2000, 14 days after receiving the submission on February 4, 2000.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5870.

Submission Details

510(k) Number K000363 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2000
Decision Date February 18, 2000
Days to Decision 14 days
Submission Type Special
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code DDC — Thyroglobulin, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5870